Publications by authors named "Fujiang Xu"

Claim this Profile
A
Albumin-globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients.
Kaixiang He, Fujiang Xu, Li Xiang, Yuhao Luo

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EZH2 selective inhibitor ZLD1039 attenuates UUO-induced renal fibrosis by suppressing YAP activation.
Qingling Xia, Fujiang Xu, Lidan Zhang, Wenfei Ding, Jiang Liu, Yong Xu

Mol Biomed· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis.
Bohan Zeng, Runlan Wan, Kun Chang, Jing Li, Xuanzhi Zhang, Fujiang Xu

Int J Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma.
Kun Chang, Yingji Chen, Xuanzhi Zhang, Wei Zhang, Ning Xu, Fujiang Xu

Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor.
Hailiang Zhang, Lin Bai, Xin-Qiang Wu, Xi Tian, Jinwen Feng, Wenhao Xu, Fujiang Xu

Nat Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative proteogenomic characterization of early esophageal cancer.
Lingling Li, Dongxian Jiang, Qiao Zhang, Hui Liu, Fujiang Xu, Xue Zhang, Chen Xu

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response.
Xi Tian, Wen-Hao Xu, Fu-Jiang Xu, Hui Li, Aihetaimujiang Anwaier

Ann Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteogenomic characterization of MiT family translocation renal cell carcinoma.
Yuanyuan Qu, Xiaohui Wu, Aihetaimujiang Anwaier, Jinwen Feng, Wenhao Xu, Fujiang Xu

Nat Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of an Immune Escape-Related Signature in Clear Cell Renal Cell Carcinoma and Identification of the Relationship between IFNAR1 and Immune Infiltration by Multiple Immunohistochemistry.
Kun Chang, Fujiang Xu, Xuanzhi Zhang, Bohan Zeng, Wei Zhang

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies.
Yan Li, Chen Xu, Bing Wang, Fujiang Xu, Fahan Ma

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies.
Yan Li, Chen Xu, Bing Wang, Fujiang Xu, Fahan Ma

Nat Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated proteogenomic characterization of urothelial carcinoma of the bladder.
Ning Xu, Zhenmei Yao, Guoguo Shang, Dingwei Ye, Haixing Wang, Fujiang Xu

J Hematol Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased DNA Polymerase Epsilon Catalytic Subunit Expression Predicts Tumor Progression and Modulates Tumor Microenvironment of Hepatocellular Carcinoma.
Haijia Tang, Xiaoxin Hu, Fujiang Xu, Kefei Lin, Wenhao Xu

J Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.
Xin-Qiang Wu, Xi Tian, Fu-Jiang Xu, Yue Wang, Wen-Hao Xu

Bioengineered· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population.
Yuanyuan Qu, Jinwen Feng, Xiaohui Wu, Lin Bai, Wenhao Xu, Fujiang Xu, Xuan Zhang

Nat Commun· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.
Yuan-Yuan Qu, Rui Zhao, Hai-Liang Zhang, Qian Zhou, Fu-Jiang Xu, Xuan Zhang, Wen-Hao Xu, Wei Xu

Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma.
Wen-Jun Xiao, Fu-Jiang Xu, Xuan Zhang, Shu-Xian Zhou, Hai-Liang Zhang

Front Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APC/C synchronizes ribose-5-phosphate levels and DNA synthesis to cell cycle progression.
Yang Li, Cui-Fang Yao, Fu-Jiang Xu, Yuan-Yuan Qu, Jia-Tao Li, Wei Xu

Nat Commun· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of correlates with aggressive features and poor survival in clear cell renal cell carcinoma.
Dalong Cao, Yuanyuan Qu, Xuan Zhang, Fujiang Xu, Shuxian Zhou

J Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
Jian Ma, Kun Chang, Jingtao Peng, Qing Shi, Hualei Gan, Fujiang Xu

J Exp Clin Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma.
Fujiang Xu, Kun Chang, Jian Ma, Yuanyuan Qu, Huyang Xie

Sci Rep· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma.
Fujiang Xu, Kun Chang, Jian Ma, Yuanyuan Qu, Huyang Xie

Sci Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis